Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxSelling, General & Administrative
Others
Ratios

Groove Botanicals (GRVE) EBITDA (2016 - 2017)

Groove Botanicals' EBITDA history spans 8 years, with the latest figure at -$71223.0 for Q1 2017.

  • For Q1 2017, EBITDA rose 97.05% year-over-year to -$71223.0; the TTM value through Mar 2017 reached -$232645.0, up 91.62%, while the annual FY2025 figure was -$130834.0, 50.92% up from the prior year.
  • EBITDA for Q1 2017 was -$71223.0 at Groove Botanicals, up from -$108811.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$24287.0 in Q2 2016 and bottomed at -$2.4 million in Q1 2016.
  • The 5-year median for EBITDA is -$109837.0 (2015), against an average of -$252041.8.
  • The largest annual shift saw EBITDA plummeted 2964.23% in 2016 before it skyrocketed 97.05% in 2017.
  • A 5-year view of EBITDA shows it stood at -$123970.0 in 2013, then soared by 31.16% to -$85336.0 in 2014, then plummeted by 64.83% to -$140656.0 in 2015, then rose by 22.64% to -$108811.0 in 2016, then surged by 34.54% to -$71223.0 in 2017.
  • Per Business Quant, the three most recent readings for GRVE's EBITDA are -$71223.0 (Q1 2017), -$108811.0 (Q4 2016), and -$28324.0 (Q3 2016).